Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.

Meiling Meng, Wei Li, Shaowei Zhang, Hongyan Wang, Jianhua Sheng, Jijun Wang, Chunbo LiPubMed 2015 · DOI

Abstract

This study systematically reviewed and evaluated all relevant RCTs and found that adjunctive aripiprazole is effective and safe to use in the treatment of antipsychotic-induced HPL. However, the low quality of some of the studies, the incomplete methodological information provided for most of the studies, and the relatively short follow-up time of the studies raises question about the validity of the results. Further work that resolves these methodological and reporting issues is needed.
BibTeX
@inproceedings{meng2015using,
  author = {Meiling Meng and Wei Li and Shaowei Zhang and Hongyan Wang and Jianhua Sheng and Jijun Wang and Chunbo Li},
  title = {{Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.}},
  booktitle = {PubMed},
  year = {2015},
  doi = {10.11919/j.issn.1002-0829.215014},
}

Loading related content...

Figure